Kantipur Pharmaceuticals Lab Limited Issuing IPO Shares to Locals of Kavrepalanchowk District And Nepalese Employed Abroad From Mangsir 10

Summary

Kantipur Pharmaceuticals Lab Limited is opening an IPO for project-affected locals of Kavrepalanchowk and Nepali citizens working abroad from Mangsir 10. The company, which manufactures veterinary pharmaceutical products in Panchkhal, has also had its issuer rating reaffirmed by CARE Ratings Nepal at ‘CARE-NP BB+ (Is)’.

Key Points
  • Kantipur Pharmaceuticals Lab Limited is issuing IPO shares to project-affected locals of Kavrepalanchowk District and Nepalese citizens working abroad starting Mangsir 10, 2083.
  • The company will issue 17,00,000 public shares from its Rs. 80 crore issued capital, including 8,00,000 shares reserved for local project-affected residents and 90,000 shares for Nepali workers abroad.
  • Muktinath Capital Limited has been appointed as the issue manager for the public offering.
  • CARE Ratings Nepal Limited has reaffirmed Kantipur Pharmaceuticals Lab Limited’s issuer rating at ‘CARE-NP BB+ (Is)’, and the company manufactures veterinary pharmaceutical products in Panchkhal-7, Kavre.
Article image